Home / Cardiovascular system / Evolocumab
ATC C10AX13 · Other Lipid Modifying Agents · updated 2 Nov 2026
Evolocumab shortage
As of 2 Nov 2026, Evolocumab has a reported shortage in 1 of the 16 countries we track (France), covering 1 product from 0 companies.
Is there an Evolocumab shortage?
Yes. As of 2 Nov 2026, Evolocumab is reported short in 1 of the 16 countries we track: France. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Compared with similar medicines
ATC group C10AX · Other Lipid Modifying AgentsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| FR | Repatha 140 mg, solution injectable en stylo prérempli limited | 24 Jul 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Evolocumab shortage?
Yes. As of 2 Nov 2026, Evolocumab is reported short in 1 of the 16 countries we track: France. No company has given a return date.
When will Evolocumab be back in stock?
No return date has been given; France: no date given. These are company estimates reported to each authority.
Why is Evolocumab in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Evolocumab shortages?
The registers do not name the companies.